T1	p 100 117	ADHD and Autism .
T2	p 128 198	deficit hyperactivity disorder ( ADHD ) and autism spectrum disorder (
T3	p 531 532	2
T4	p 610 640	. Age-matched boys with ADHD (
T5	p 652 653	(
T6	p 676 678	21
T7	p 995 1004	each drug
T8	p 1115 1147	, ASD boys underactivated medial
T9	p 1199 1214	and ADHD boys .
T10	p 1345 1362	ASD boys relative
T11	p 1399 1417	ADHD boys relative
T12	p 1484 1490	ADHD .
T13	p 1558 1561	and
T14	i 24 34	Fluoxetine
T15	i 317 366	selective serotonin reuptake inhibitors ( SSRIs )
T16	i 596 600	SSRI
T17	i 711 746	magnetic resonance imaging ( fMRI )
T18	i 794 801	twice ,
T19	i 832 853	Fluoxetine or placebo
T20	i 874 892	placebo-controlled
T21	i 1077 1081	fMRI
T22	i 1107 1114	placebo
T23	i 1173 1174	)
T24	i 1281 1291	Fluoxetine
T25	i 1294 1298	mPFC
T26	i 1421 1428	placebo
T27	i 1535 1539	mPFC
T28	o 38 73	Medial Prefrontal Cortex Activation
T29	o 100 104	ADHD
T30	o 109 149	Autism . Attention deficit hyperactivity
T31	o 217 239	function abnormalities
T32	o 380 401	cognitive flexibility
T33	o 406 422	improve behavior
T34	o 481 521	and disorder-specific brain dysfunctions
T35	o 576 581	acute
T36	o 1141 1172	medial prefrontal cortex ( mPFC
T37	o 1242 1274	decreased precuneus activation .
T38	o 1294 1309	mPFC activation
T39	o 1314 1326	up-regulated
T40	o 1464 1480	task performance
T41	o 1535 1550	mPFC activation
T42	o 1574 1582	reversal